Poster 2016-A : AUTOMATED AI-BASED MORPHOMETRIC ANALYSIS OF FIBROSIS REVEALS SIGNIFICANT CHANGES IN T2DM VS NON-T2DM MASH PATIENTS WITH ADVANCED FIBROSIS
NASH / NAFLDPoster Morphometric Digital Pathology Analysis Reveals Differential Effects Of Lanifibranor And Semaglutide In The Biopsy-Confirmed Gan Dio-Nash Mouse Model
NASH / NAFLDPoster MORPHOMETRIC DIGITAL PATHOLOGY CONFIRMS CLINICAL TRANSLATABILITY FOR LANIFIBRANOR AND SEMAGLUTIDE IN BIOPSY-CONFIRMED GAN-DIO-NASH MICE
PosterNASH / NAFLD MORPHOQUANT-LIVER, AN AUTOMATED PATHOLOGIST-INDEPENDENT MORPHOMETRIC SOFTWARE, IDENTIFIED SIGNIFICANT DIFFERENCES BETWEEN STEATOTIC AND MASH LIVER BIOPSIES
PosterNASH / NAFLD Morphometric Analysis Of Sonic Hedgehog In Non-Alcoholic Fatty Liver And Steatohepatitis Patients By Morphoquant: A Potential Biomarker Of Disease Severity
NASH / NAFLDPoster Morphoquanttm The First Fully-Automated Morphometric Software For The Assessment Of Liver Biopsy, Reveals Significant Differences Between Non- Alcoholic Fatty Liver And Steatohepatitis Biopsies
PAHPoster Effects of the Oral Angiotensin II Type 2 Receptor Agonist C21 in Sugen-Hypoxia Induced Pulmonary Hypertension in Rats
PAHPoster High-Throughput, Automated Analysis Of Blood Vessel Histomorphometry In Two Rat Models Of Pulmonary Arterial Hypertension
PAHPoster Dual High-Throughput Automated Analysis Of Histomorphometric Markers Of Fibrosis And Emphysema In Two Bleomycin-Induced Mouse Models Of Pulmonary Fibrosis
Paris Nash 2021NASH / NAFLDPoster Distribution Of Lipid Vesicle Size As Potential Marker Of Nas Severity: Assessment With Morphoquant-Nash And Mri
